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The endogenous lysosomal cysteine protease inhibitor SERPINB3 (squamous cell carcinoma
antigen 1, SCCA1) is elevated in patients with cervical cancer and other malignancies. High
serum SERPINB3 is prognostic for recurrence and death following chemoradiation therapy.
Cervical cancer cells genetically lacking SERPINB3 are more sensitive to ionizing radiation
(IR), suggesting this protease inhibitor plays a role in therapeutic response. Here we
demonstrate that SERPINB3-deﬁcient cells have enhanced sensitivity to IR-induced cell death.
Knock out of SERPINB3 sensitizes cells to a greater extent than cisplatin, the current standard
of care. IR in SERPINB3 deﬁcient cervical carcinoma cells induces predominantly necrotic cell
death, with biochemical and cellular features of lysoptosis. Rescue with wild-type SERPINB3
or a reactive site loop mutant indicates that protease inhibitory activity is required to protect
cervical tumor cells from radiation-induced death. Transcriptomics analysis of primary cervix
tumor samples and genetic knock out demonstrates a role for the lysosomal protease
cathepsin L in radiation-induced cell death in SERPINB3 knock-out cells. These data support
targeting of SERPINB3 and lysoptosis to treat radioresistant cervical cancers.
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ervical cancer remains a leading cause of cancer death for
women worldwide1. Despite efforts to improve screening
and human papilloma-virus (HPV) vaccination rates,
overall mortality from the disease has not changed substantially
in the last several decades1,2. Deﬁnitive chemoradiation is the
standard of care for most women with cervical cancer, but is
associated with recurrence rates as high as 30–70%3,4, implying
that many cervical cancers display inherent or adaptive cellular
resistance to these therapies. For women who experience recurrent disease following chemoradiation therapy, less than 5% of
women survive beyond ﬁve years3. Thus, there is an unmet need
to understand of the molecular mechanisms of resistance to
radiation and chemotherapy in cervical cancer, with the goal of
developing novel therapies for both upfront and salvage therapy.
We previously demonstrated that elevated serum squamous
cell carcinoma antigen (SCCA) is independently prognostic for
recurrence and survival following deﬁnitive radiation therapy for
cervical cancer5,6. Moreover, we found that failure of serum
SCCA to normalize by the fourth week of treatment was an early
indicator of failed response to therapy as indicated by positive
post-therapy FDG-PET, and increased recurrence and death6.
Clinical serum SCCA assays measure levels of SERPINB3 and
SERPINB4 proteins, also known as SCCA1 and SCCA2, respectively. These proteins share high homology, and diverge in amino
acid sequence primarily within the carboxy-terminal reactive site
loop (RSL), which serves as a pseudo-substrate for speciﬁc
proteases7. Binding and cleavage of the RSL by a target protease
results in a rapid conformational change in the SERPIN, preventing further processive proteolysis of the SERPIN and results
in a covalently bound SERPIN-protease complex that is ultimately degraded8.
SERPINB3 is an intracellular cysteine protease inhibitor that is
upregulated in many autoimmune diseases and cancer5,9–14. The
Caenorhabditis elegans (C. elegans) homologue of SERPINB3,
SRP-6, protects against lysosomal damage and organismal death
by inhibiting cysteine protease activity induced by diverse stressors including hypotonic saline, hydrogen peroxide, DNAdamage and reactive oxygen species15. This phenotype can be
rescued in the srp-6 null animal by driving expression of wildtype SRP-6, but not RSL-mutant SRP-6, suggesting that inhibition
of cysteine proteases is necessary for cytoprotection. SERPINB4
demonstrates speciﬁcity for chymotrypsin-like serine proteases
in vitro16, and has been shown to inhibit granzyme M-induced
cell death when overexpressed in HeLa cells, but does not have
other well-described cellular functions17.
While high levels of SERPINB3 in the serum is associated with
poor response to RT in patients with cervical cancer, it is not clear
if SERPINB3 impacts radiation response on a cellular level. We
hypothesized that SERPINB3 serves as a radioprotective factor in
cervical cancer cells. Indeed we found that cervical cancer cell
lines engineered by CRISPR-Cas9-mediated gene editing of the
SERPINB3 locus resulting in knockout (B3-KO) were signiﬁcantly
more sensitive to ionizing radiation in vitro compared to isogenic
control cells, as determined by clonogenic cell survival assay9. The
molecular mechanism of protection against radiation is unknown.
Murakami et al found that transient transfection of vector-driven
SERPINB3 into 293 T human embryonic kidney cells resulted in
higher survival as measured by MTT assay up to 36 h after
treatment with radiation18. Examination of caspases important
for apoptosis demonstrated decreased levels of caspase 9 cleavage
and caspase-3 activity in cells transfected with SERPINB3.
Based on these ﬁndings the authors concluded that
SERPINB3 suppresses radiation-induced apoptosis. While the
regulation of caspases is important in apoptotic cell death pathways, exogenous stressors such as IR often induce multiple cellular death pathways within a population of cells. Additionally,
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radiation does not engage apoptosis effectively in most solid
tumors due to common dysregulation of pro-apoptotic
pathways19. Thus, the precise molecular mechanism of protection by SERPINB3 against radiation remains unknown.
In the current study, we found that the mechanism of
SERPINB3-mediated radioprotection in cervical cancer cells is
inhibition of cell death. Moreover, we identiﬁed the primary
mode of cell death induced by radiation in SERPINB3-KO cells as
lysoptosis-like, a distinct regulated lysosome-mediated necrosis
pathway described in detail the companion publication (Luke
et al, “Lysoptosis is an ancient and evolutionarily-conserved cell
death pathway moderated by intracellular serpins,” manuscript #
COMMSBIO-20-2781-T). The central hallmark of lysoptosis is
lysosomal membrane permeability with leakage of active cathepsin proteases, namely cathepsin L, into the cytosol, and is
inhibited in the presence of SERPINB3 or pharmacologic cysteine
protease inhibitors and selective cathepsin L inhibitors. Here we
show that radiation induces lysoptosis-like necrotic cell death,with little to no evidence of apoptotic cell death, necroptosis,
pyroptosis or ferroptosis. Additionally, the SERPINB3 RSL is
required for protection against radiation, and knockout of the
lysosomal cysteine protease cathepsin L (CTSL) partially protected SERPINB3-KO cervix tumor cells from radiation-induced
death, further supporting the mechanism of lysosomal protease
inhibition. To our knowledge, this is the ﬁrst report that SERPINB3 protects cancer cells against radiation-induced necrosis,
and does so via inhibition of the lysosomal cysteine protease
cathepsin L. Moreover, we present evidence that ionizing radiation induces a lysosome-mediated cell death pathway in cancer
cells, particularly when a protective factor is eliminated, suggesting a potential vulnerability for targeting radioresistant
cancers.
Results
SERPINB3-KO cells are more sensitive to radiation and
cisplatin-induced cell death. For these studies, a panel of cervical
cancer cell lines was selected to provide the most clinically relevant
models. Two cell lines with high levels of SERPINB3 (SW756 and
HT3) and two with low to undetectable levels of SERPINB3 (SiHa
and C33A), had varying sensitivity to radiation as determined by
clonogenic cell survival, with the cell lines expressing SERPINB3
more radioresistant than those without SERPINB3 (Supplemental
Fig. 1a, b). Importantly, SW756 with a single integrated copy of the
HPV type 18 and SiHa with an integrated copy of HPV type 16,
were selected to represent commonly HPV-associated cancers.
Conversely, HT3 and C33A cell lines, which do not have HPV
DNA, were selected to represent the ~10% of HPV-negative cervical
cancers (Supplemental Fig. 1a, b). Patients with HPV-negative
cervical cancers in some clinical series have worse outcomes following chemoradiation20, and in the case of head and neck squamous cell carcinoma, these cancers are more likely to be resistant to
radiation treatment21,22. Thus, we felt it important to understand
the impact of SERPINB3-KO on tumor cells of both HPV-positive
and HPV-negative origins.
To determine if SERPINB3 protects cells against stress-induced
death through a conserved mechanism similar to SRP-6, we ﬁrst
quantiﬁed cell death by exclusion of Sytox™ nucleic acid stain in
cells treated with sham or increasing doses of radiation over a
time course of several days. We found that clonal cell lines with
CRISPR-Cas9-mediated SERPINB3-knockout (referred to as “B3KO”) in both HT3 and SW756 cervical cancer cells had
signiﬁcantly higher percent cell death at every dose and every
timepoint following treatment with IR, compared to cell lines
with the CRISPR-Cas9 vector containing no guide RNA (referred
to as “B3-WT”), shown in Fig. 1a, b. We found up to a 20%
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than the radiosensitizing effect seen with cisplatin chemotherapy.
Dose modifying factors (DMF, determined as the ratio of the dose
resulting in 10% surviving fraction compared to control
untreated) was greater for single gene B3-KO compared to
cisplatin in both SW756 (DMF 0.69 for B3-KO versus 1.01 for
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Fig. 1 SERPINB3-KO cells are more sensitive to radiation and cisplatin-induced cell death. a, b Western blot showing SERPINB3 in B3-WT and B3-KO
cell lines. Percent Sytox-positive CRISPR-Control (B3-WT) and SERPINB3-KO (B3-KO) cells at indicated time points after 2, 10, or 30 Gy RT in SW756 (a)
and 2, 4, or 10 Gy in HT3 (b). P-value displays sample variation for two-way ANOVA with replicates over time, n.s. not signiﬁcant (bar = mean of triplicate
wells, 2–4 ﬁelds of view per well, error bars = standard deviations, one representative of three biologic replicates shown). c Representative confocal
ﬂuorescent images of SW756- and HT3-B3-WT and -B3-KO Sytox (pseudo-colored green) and merge of Hoescht (pseudo-colored blue) and Sytox images
at 84 h post-treatment. Scale bar indicates 50 µm. d, e Percent Sytox-positive cells following treatment with increasing doses of RT with or without cisplatin
at 96 h in SW756 (d) and HT3 (e) background (bar = mean of triplicate wells, 2–4 ﬁelds of view per well, error bars = standard deviations, one
representative of three biologic replicates shown). Student’s t-test p-values shown, n.s. = p-value not signiﬁcant, * = p < 0.05, ** = p < 0.05 for all
comparisons of B3-WT vs B3-KO, except where indicated. f, g Clonogenic survival of B3-WT or B3-KO cells treated with increasing doses of RT with or
without cisplatin in SW756 (f) or HT3 (g) background. Individual data points from a representative experiment (one of three biologic replicates) with ﬁt
linear quadratic equation. DMF for 10% surviving fraction is shown relative to that of Control cells treated with vehicle (reference).
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Fig. 2 SERPINB3-KO tumors are more sensitive to radiation in vivo. a, b Mean tumor volume with standard error is plotted over time after RT for HT3B3-WT and –KO ﬂank tumors treated with sham (a), or 10 Gy RT (b). Number of mice in each group as indicated in the legend, dashed line at mean volume
at time of RT. Two-way ANOVA analysis p-value displayed on each graph. c Calculated tumor doubling (ln2/(% volume change per day)) is shown for
HT3-B3-WT and –B3-KO cells after sham or 10 Gy. Individual tumors with mean and standard error are shown. P-values from paired t-test comparisons are
shown. d, e Mean tumor volume with standard error is plotted over time after RT for SW756-B3-WT and –KO ﬂank tumors treated with sham (d), or 10 Gy
RT (e). Number of mice in each group as indicated in the legend, dashed line at mean volume at time of RT. Two-way ANOVA analysis p-value displayed
on each graph. f Calculated tumor doubling (ln2/(% volume change per day)) is shown for SW756-B3-WT and –B3-KO cells after sham or 10 Gy.
Individual tumors with mean and standard error are shown. P-values for paired t-test comparisons are shown.

cisplatin) and HT3 (DMF 0.73 for B3-KO versus 0.96 for
cisplatin), and cisplatin did not further sensitize B3-KO cells to
radiation (DMF 0.69 vehicle versus 0.67 cisplatin for HT3, and
0.73 vehicle versus 0.75 cisplatin for SW756). Cisplatin did reduce
plating efﬁciency of HT3 but not SW756 cells (Supplemental
Fig. 1c, d), indicating a cytotoxic effect in the absence of
radiosensitization, which has been previously reported with
cisplatin in cervix cancer cell lines23.
SERPINB3-KO tumors are more sensitive to radiation in vivo.
To determine the role of SERPINB3 in a p53 mutant cervix tumor
in vivo, we established subcutaneous ﬂank xenografts of the HT3
cell line in female athymic nude mice, with either B3-WT or B3KO clones. Sham-treated HT3-B3-WT and –B3-KO tumors grew
at a similar rate in vivo (Fig. 2a). Not surprisingly, HT3-B3-WT
4

tumors were resistant to radiation, and after a single high dose
but clinically relevant fraction of 10 Gy (recapitulating high dose
rate brachytherapy) we observed no tumor regression (Fig. 2b).
All but 1 of the tumors doubled in size by three weeks after
irradiation (Supplemental Fig. 1e). In contrast, all but one HT3B3-KO xenografts showed tumor regression followed by sustained tumor growth delay (Fig. 2b), and less than 50% of the
tumors doubled over the course of the experiment (Supplemental
Fig. 1e). Additionally, four of ﬁve tumors in the irradiated HT3B3-WT group also developed ulcers requiring sacriﬁce compared
to none of the irradiated HT3-B3-KO tumors. Calculated tumor
doubling time (ln 2/(% volume change per day)) as described by
Lee et al.24 for individual xenografts is shown in Fig. 2c.
SW756-B3-KO xenograft tumors took longer to reach the
target size for radiation treatment, but grew at a similar rate to

COMMUNICATIONS BIOLOGY | (2022)5:46 | https://doi.org/10.1038/s42003-021-02893-6 | www.nature.com/commsbio

ARTICLE

COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-021-02893-6

SW756-B3-WT tumors once established (Fig. 2d). SW756 tumors
were more radiosensitive; a single fraction of 10 Gy induced
tumor growth delay in both B3-WT and B3-KO tumors with B3KO tumors regressing in size prior to delayed regrowth (Fig. 2e).
Fewer radiated B3-KO tumors reached pre-radiation size
compared to B3-WT tumors (Supplemental Fig. 1f), and tumor
doubling time of B3-KO irradiated tumors was signiﬁcantly
longer compared to sham-treated tumors, while tumor doubling
time of irradiated B3-WT tumors was not different from shamtreated B3-WT tumors (Fig. 2f).

4 Gy by quantifying DNA content (Fig. 3a–d). Sham-treated
HT3-B3-KO cells had 7% cells in S-phase compared to 6% in B3WT (Fig. 3b), and sham-treated SW756-B3-KO cells had 40% of
cells in S-phase compared to 32% in B3-WT cells (Fig. 3d). Shamtreated SW756-B3-KO cells had 2% of cells in G2/M phase
compared to 5% of B3-WT, and G2/M population was not different in sham-treated HT3 cells. In response to radiation,
accumulation of cells in the G2/M phase was not different in B3WT and B3-KO cells with the SW756 cell-line background (HPV
positive, p53 wild-type). Cell cycle distribution did not change
following RT for either HT3-B3-WT or B3-KO cells (HPV
negative, p53 mutant), consistent with aberrant cell cycle checkpoint response commonly seen in p53 mutant cells (Fig. 3a, b).
Reduced capacity to repair double strand DNA breaks induced
by ionizing radiation results in decreased clonogenic survival.
Thus, in order to determine if DNA-damage repair capacity
contributes to radiosensitivity of B3-KO cells, we quantiﬁed
gamma-H2AX (ɣH2AX) foci in B3-WT and B3-KO cells treated
with sham or 2 Gy RT at 30 min and 24 h post-treatment as a
surrogate for repair of DNA damage. As expected, increased

Increased radiation-induced cell death in B3-KO cells is not
explained by cell cycle distribution or compromised repair of
DNA double strand breaks. Sensitivity to radiation-induced
death can vary depending on the phase of cell cycle at the time of
treatment. Cells in S phase at the time of radiation are typically
more radioresistant and those in G2/M are more radiosensitive25.
Therefore, we analyzed cell cycle distribution of unsynchronized
sham-treated B3-WT and B3-KO cells and re-sorting 48 h after
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Fig. 3 Increased B3-KO cell death is not explained by cell cycle distribution or impaired DNA-damage repair. a, c Representative histograms for DNA
content determined by propidium iodide staining and ﬂow cytometry analysis of HT3 (a) or SW756 (c) cells, with PI intensity on the x-axis. b, c Mean and
standard deviation quantiﬁed cell cycle distribution for triplicate repeats of HT3 (b) and SW756 (d) experiments. Individual data points are shown, and
asterisks indicate students t-test p-value < 0.05. e ɣH2AX foci per nucleus in HT3- and SW756-B3-WT and -B3-KO cells 30 min or 24 h after treatment
with sham or 2 Gy. Dots represent individual nuclei, with mean and S.D. overlay. N.s. not signiﬁcant, * = p < 0.05. f Representative nuclei shown for each
condition with Hoechst 33342 (blue) and ɣH2AX (green) merge. White scale bars shown. g, h Western blot analysis of total cell lysates from HT3- and
SW756-B3-WT and –B3-KO cells 30 min and 24 h after treatment with sham (S) or 2 Gy radiation. Band intensity of p-ATM normalized to band intensity
of GAPDH is displayed under p-ATM blot.
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ɣH2AX foci were observed at the 30 min timepoint in all cell lines
(foci/nucleus increased 4–5 fold, Fig. 3e). Foci resolved to sham
levels by 24 h in all cell backgrounds, suggesting that the DNAdamage repair machinery is functioning similarly in both B3-WT
and B3-KO cells. Interestingly, the mean number of foci per
nucleus was moderately but reproducibly higher in HT3-B3-KO
cells compared to HT3-B3-WT cells at 30 min post-2Gy,
potentially indicating higher direct DNA damage in these cells,
or perhaps more likely, different kinetics of response to DNA
damage (Fig. 3e). Representative ﬂuorescent images are shown in
Fig. 3f. We also evaluated phosphorylation of ataxia-telangiectasia
mutated (ATM) by Western blot as an indicator of response to
DNA damage; levels of phosphorylated-ATM were increased
30 min after 2 Gy radiation, and decreased by 24 h in all cell
backgrounds (Fig. 3g, h). There was no apparent difference in
30 min ATM phosphorylation between HT3-B3-WT and –B3KO cells.
Cell death in B3-KO cells following RT suggests potential
engagement of multiple cell death mechanisms including apoptosis/caspase-dependent cell death and lysosome-dependent
necrosis with features of lysoptosis. While ionizing radiation is
known to induce cell death in tumor cells, the precise mechanism of
this demise is unclear and could potentially involve multiple cell
death pathways. Thus, we took a multi-faceted approach to determine which cell death mechanism(s) occur in response to radiation
in B3-WT and B3-KO cells over time. First, we evaluated cells with
transmission electron microscopy (TEM) to determine if cell death
morphology induced by ionizing radiation was primarily apoptotic
or necrotic. Untreated B3-WT and B3-KO cells showed cells with
large nuclear:cytoplasmic ratio as expected for carcinoma cells,
without apparent differences in morphology (Fig. 4a, d, g, j). In
contrast, when treated with IR, dead B3-KO cells displayed necrotic
morphology in both HT3 and SW756 (Fig. 4b, e, h, k), with swollen
and disintegrating nuclei (note size of B3-KO 10 Gy nucleus is
~20–30 μM in diameter compared to 10-15μM in sham-treated and
B3-WT 10 Gy conditions), and highly vacuolated cytoplasm. High
magniﬁcation images show breaks in the plasma membrane, cytoplasmic clearing, and largely normal mitochondrial morphology
(Fig. 4f, l). LDH release was detected in irradiated B3-KO cells at
similar time points, consistent with plasma membrane permeability
(Supplemental Fig. 1g). Irradiated HT3-B3-WT and SW756-B3WT cells displayed enlarged cells with more frequent mitochondria,
intact nuclear envelop (Fig 4c, i). Blinded scoring of randomly
sampled TEM images by two reviewers shows a higher proportion
of cells with necrotic morphology in irradiated B3-KO cells (~25%)
compared to irradiated B3-WT cells (<5%) (Fig. 4m). Vacuoles seen
in the irradiated B3-KO cells were membrane-bound, consistent
with lysosomes, and in many cases these membranes were ruptured,
releasing their contents into the cytoplasm (Fig. 4n–q).
Second, cells were treated with increasing doses of RT and
analyzed by Western blot and ﬂuorescent microscopy at 24 h
intervals up to 96 h. Western blots were probed for markers of
multiple regulated cell death pathways including cleavage of endeffector caspase-3 and caspase-7 (apoptosis), and Poly (ADPribose) polymerase (PARP) cleavage products (apoptosis),
gasdermin D (GSDMD) cleavage to p30 pore-forming product
(pyroptosis), and phosphorylation of mixed lineage kinase
domain like pseudokinase (MLKL) (necroptosis), and receptor
interacting serine/threonine kinase 3 (RIPK3) (necroptosis). Of
note, there are no accepted markers of ferroptosis or lysoptosis
that can be determined by Western blot. Cell death was quantiﬁed
in parallel using Sytox exclusion and positive controls for
caspase and PARP cleavage (etoposide [85 µM]), GSDMD
cleavage (electroporated LPS [12.5 µg/mL]), and MLKL/RIPK3
6

phosphorylation (TNFα [20 ng/mL] + BV6 [100 nM] + ZVAD
[50 µM]) were performed simultaneously (Fig. 5a, b, and
Supplemental Fig. 2a). In HT3 cells, caspase-3 (CC-3), caspase7 (CC-7) and PARP cleavage was detected at later time points
with an apparent dose response (Fig. 5a, Supplemental Fig. 2a).
There was qualitatively more caspase-3/7 cleavage in HT3-B3-KO
cells compared to B3-WT cells, though low compared to the
amount of cell death seen at those time points and compared to
the apoptosis positive control (Fig. 5a, Supplemental Fig. 2b). In
SW756 cells, no caspase-3 or caspase-7 cleavage was detected
even 96 h after 30 Gy (Fig. 5b). We found no evidence of GSDMD
cleavage, or p-MLKL, p-RIPK3/RIPK1 (markers of pyroptosis
and necroptosis, respectively) in either HT3 or SW756 cells
(Fig. 5a, b). Additional controls to demonstrate detection of
markers by Western blot are shown in Supplemental Fig. 2b-d,
including treatment with inducers and inhibitors of apoptosis
(Supplemental Fig. 2b), necroptosis (Supplemental Fig. 2c), and
pyroptosis (Supplemental Fig. 2d).
As radiation therapy-induced senescence can also contribute
to decreased clonogenic survival, we evaluated if markers of
senescence were differentially induced by RT in B3-WT and B3KO cells. Sham-treated SW756-B3-KO cells had slightly higher
percent positive senescence associated beta-galactosidase (SAβgal) cells compared to SW756-B3-WT cells (~15% versus
~10%) 24 h after plating (sham, 0 h, Fig. 5c, d); however, there
was no difference 96 h after sham-treatment, and SA-βgalpositive cells were not signiﬁcantly increased in either SW756B3-WT or –B3-KO cells after 30 Gy RT (Fig. 5c, d). HT3 cells
did not have any SA-βgal-positive cells in any ﬁelds of view
either with sham or 10 Gy RT (Supplemental Fig. 3). Similarly,
Western blot analysis for BCL-2 and BAX, which are commonly
increased and decreased, respectively, in senescent cells, were
not different between B3-WT and B3-KO cells, and did not
change in either direction following treatment with ionizing
radiation (Fig. 5e).
Thirdly, pharmacologic inhibitors of pan-caspase activity
(qVD-OPH [1uM]), necroptosis (necrostatin-1 [10 µM]), pyroptosis (VX-765, 50 µM), and ferroptosis (ferrostatin-1 [50 nM])
were incubated with cells beginning 24 h after treatment with
ionizing radiation. The pan-caspase inhibitor qVD-OPH attenuated cell death in both B3-WT and B3-KO cells by about 10% in
HT3 cells, but not SW756 cells (Fig. 5f). Necrostatin-1,
ferrostatin-1, and VX-765 did not inhibit radiation-induced cell
death in either B3-WT or B3-KO cells in either cell background
(Fig. 5f). Higher concentrations of ferrostatin-1, a potent lipid
radical-trapping antioxidant, did not inhibit radiation-induced
death in either B3-WT or B3-KO cells, despite effective complete
inhibition of cell death induced by the ferroptosis-inducer erastin
(Supplemental Fig. 4a). Similarly, chelation of intracellular iron
using deferoxamine did not inhibit radiation-induced cell death
in either B3-WT or B3-KO cells (Supplemental Fig. 4b). Given
known cellular requirement of iron for homeostasis and eventual
toxicity, the deferoxamine was added at various time points after
radiation, with the goal of determining requirement of iron for
cell death.
Since caspase-3 and caspase-7 cleavage was detected in vitro,
we investigated hallmarks of apoptotic cell death in tumors
in vivo following radiation. Flank xenografts were established in
nude athymic mice from the HT3 cell lines as described above,
randomized to sham or 10 Gy radiation, and harvested 96 h postRT. Percent TUNEL positive nuclei and IHC for cleaved-caspase3 (CC-3) was quantiﬁed on tissue sections. Absolute levels of
TUNEL positive nuclei (Fig. 5G, representative images Fig. 5H-K)
and CC-3-positive cells (Fig. 5l, representative images Fig. 5m-p)
were and remained low (<~10%) in both B3-WT and
B3-KO cells.
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stressors15. This cell death mechanism has been further characterized and termed lysoptosis (Good et al, “Lysoptosis is an
ancient and evolutionarily-conserved cell death pathway moderated by intracellular serpins,” manuscript # COMMSBIO-202781-T). Given the conserved molecular function of SERPINB3
as an intracellular lysosomal cysteine protease inhibitor, we
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Fig. 5 Cell death in B3-KO cells following RT suggests potential engagement of multiple cell death mechanisms including apoptosis/caspasedependent cell death and lysosome-dependent necrosis with features of lysoptosis. a Western blot of total cell lysates from HT3-B3-WT, -B3-KO cells
at indicated time points following sham or increasing doses of RT. Positive control lysates from HT3-B3-WT cells treated with etoposide (A for apoptosis),
or nucleofected LPS (P for pyroptosis), and HT29 cells treated with TNFα, BV6 and ZVAD-fmk (N for necroptosis) are shown in the center of the blot.
Relative intensity of cleaved-caspase-3 (CC-3) and cleaved-caspase-7 (CC-7) is shown normalized to intensity of actin bands, using the positive control for
apoptosis as reference. Histogram shows % Sytox-positive cells for each condition determined in parallel (bar = mean of triplicate wells, 2–4 ﬁelds of view
per well, error bars = standard deviations). Full length GSDMD indicated by black asterisk, and p30 cleavage product indicated by black arrow. PhosphoRIPK3 band (~60 kDa) is indicated by a red arrow, ~75 kDa band on SW756 blot (indicated by red asterisk) is residual PARP antibody signal from previous
blotting. b Western blot of total cell lysates from SW756-B3-WT, -B3-KO cells at indicated time points following sham or increasing doses of RT. Positive
control lysates from HT3-B3-WT cells treated with etoposide (A for apoptosis), or nucleofected LPS (P for pyroptosis), and HT29 cells treated with TNFα,
BV6 and ZVAD-fmk (N for necroptosis) are shown in the center of the blot. These positive control lysates were generated concurrently with the
experiment. Histogram shows % Sytox-positive cells for each condition determined in parallel. c Representative light ﬁeld images of SA-βgal stained
SW756-B3-WT or B3-KO cells 96 h after treatment with sham or 30 Gy, scale bars = 50 μm. d Quantitation of percent positive X-gal staining cells with
individual data points, mean and standard deviation. Statistical tests are t-test comparisons except ANOVA as noted, * = p < 0.05, n.s. = not signiﬁcant.
e WB of total cell lysates from HT3-B3-WT or -B3-KO or SW756-B3-WT or –B3-KO cells treated as indicated. Blots were probed with anti-BCL-2, anti-BAX
and GAPDH as a loading control, with quantiﬁed band intensity below, normalized to GAPDH. f Percent Sytox-positive HT3-B3-WT or –B3-KO cells (left)
or SW756-B3-WT or –B3-KO cells (right) treated with indicated pharmacologic inhibitors 24 h after sham or radiation. (bar = mean of triplicate wells, 2–4
ﬁelds of view per well, error bars = standard deviations, individual data points shown). g Percent TUNEL + nuclei / total nuclei determined on TUNEL
stained formalin ﬁxed parafﬁn embedded sections from indicated tumors (an entire tissue section was analyzed for n = 2 mice per group, n = 3 for B3-WT
sham). Bar height indicates mean. h–k representative images of TUNEL staining. Scale bar = 40 µm. l Histogram of percent cleaved-caspase-3 (CC3) + nuclei / total nuclei determined on IHC with CC-3 antibody stained from indicated tumors (an entire tissue section was analyzed for n = 2 mice per
group, n = 3 for B3-WT sham). Bar height indicates mean, * = p < 0.05, n.s. = not signiﬁcant. m–p representative images of CC-3 staining. Scale
bar = 40 µm. Full slide digital images are available at: https://app.histowiz.com/shared_orders/2ccb0ce8-e4e1-41d1-8f75-a0e621ced36e/slides/.

hypothesized that cervical tumor cells lacking SERPINB3 would
be susceptible to lysosomal membrane permeability and lysosomal rupture following an insult such as ionizing radiation. TEM
of irradiated B3-KO cells showed evidence of vesicular membrane
rupture reminiscent of lysosomal membrane permeability in both
HT3 and SW756 cells (Fig. 4n–q). To determine if lysosomal
membrane integrity was lost prior to cell death or occurred as a
postmortem event, we performed live-cell time-lapse confocal
microscopy to observe cells in the process of dying. Lysosomes
were marked with the acidophilic dye LysoTracker™-deep red
(pseudo-colored green), and cell membrane permeability as a
measure of cell death was determined by propidium iodide
(pseudo-colored red). B3-WT or B3-KO cells were treated with
10 Gy and imaged during a period of expected high percent death,
beginning ~72 or 96 h after treatment. Dying B3-KO cells treated
with radiation lost lysosomal integrity prior to loss of cell
membrane integrity (Fig. 6a, c). HT3-B3-WT cells, in contrast,
showed a delayed loss of some LysoTracker staining after
becoming PI positive (Fig. 6b, d).
Treatment of cells with the cysteine protease inhibitor E64d
inhibited radiation-induced cell death in HT3-B3-WT and to a
greater degree in HT3-B3-KO cells (Fig. 6e), providing further
supporting evidence that lysosomal protease activity is important
for cell death, particularly in the absence of SERPINB3.
The reactive site loop of SERPINB3 and inhibition of cathepsin
L activity is required to protect cervical cancer cells against
radiation-induced death and to promote tumor growth. To
determine if SERPINB3 is sufﬁcient to increase radioresistance in
cervical cancer cells, SiHa (HPV16 + /p53 wild-type) and C33A
(HPV-/p53 mutant) cell lines with no detectable SERPINB3
protein were used to generate stable clones expressing the wildtype SERPINB3 (B3) or an empty vector control (VC), with
bicistronic expression of green ﬂuorescent protein (Fig. 7a). Clonogenic survival was signiﬁcantly higher in SiHa-B3 cells compared to SiHa-VC cells (DMF 1.25, Fig. 7b). C33A cells grow in a
manner that is partially adherent with a population of viable cells
that easily detach from the tissue culture dishes used for clonogenic survival assays, leading to high variability in the assay. Use of
soft agar suspension resulted in disaggregated colonies with

similar challenges. Therefore, the CellTiter-Glo® ATP-dependent
reagent was employed to estimate cell viability in C33A cells.
Indeed, we ﬁnd that C33A-B3 cells have higher cell viability following radiation treatment compared to C33A-VC cells, with
similar ﬁndings in the SiHa background using this assay (Fig. 7c).
To determine if the protease-inhibitory function of SERPINB3
is required for radioprotection in these cells, we generated
isogenic stable clones expressing SERPINB3 with a single alanine
to arginine amino acid substitution at the P14 residue (Schechter
and Berger numbering scheme26) of the C-terminal RSL,
corresponding to amino acid 341 in the hinge region (termed
B3-A341R). The resultant protein is a well-characterized mutant
that blocks loop insertion after cleavage by target proteases and
thus does not inhibit protease activity7. For functional analyses, a
clone with similar levels of B3-A341R protein expression
compared to the B3-expressing clone was selected (Fig. 7a), and
clonogenic survival and cell viability was compared to B3- and
VC-containing cell lines (Fig. 7b, c). Expression of B3-A341R did
not protect cells from radiation and survival was similar to VCexpressing cells (DMF 0.93 compared to VC). Flank xenograft
tumors of the C33A cell lines were established to determine effect
of B3 and B3-A341R on tumor growth and in vivo radiation
resistance. Sham-treated C33A-B3 tumors overall grew faster
than VC or B3-A341R tumors (Fig. 7d, spider plots shown in
Supplemental Fig. 5). After tumor establishment, half of the mice
were randomized to tumor-directed radiation, and B3 tumors
continued to grow after a single dose of 10 Gy compared to VC
and B3-A341R tumors (Fig. 7e, spider plots shown in Supplemental Fig. 5). Tumor doubling time was not signiﬁcantly
different in sham-treated versus 10 Gy irradiated B3-expressing
tumors, whereas tumor doubling time was longer in irradiated
VC- and A341R-containing tumors (Fig. 7f). Images of dissected
tumors to portray relative tumor size at the time of sacriﬁce for
sham irradiated and 10 Gy treated tumors are shown in Fig. 7g,
and spider plots of individual tumor growth is shown in
Supplemental Fig. 4. Taken together, these data suggest that
SERPINB3 protects cells from ionizing radiation by inhibiting
target lysosomal cysteine proteases.
In order to determine the target protease(s) of SERPINB3
in cervix cells, we ﬁrst evaluated gene expression levels of the
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nine mammalian cysteine cathepsin proteases, B cathepsin H,
cathepsin C, cathepsin X, also known as cathepsin Z, cathepsin L
(CTSL), cathepsin S, cathepsin V, cathepsin F, and cathepsin K.
RNA-seq analysis of 68 primary tumor samples collected prior to
the start of deﬁnitive radiation showed variable expression of
cathepsins B, H, C, X, and L (Fig. 7h). Cathepsins B and H are
primarily exopeptidases at acidic pH, and cathepsins X and C are
exclusive exopeptidases and therefore unlikely to be inhibited by
the pseudo-substrate bait and trap mechanism of SERPINB3
(requires endopeptidase activity). Of the ﬁve remaining cysteine
endopeptidases, we found very low or undetectable levels of
cathepsin S, cathepsin V, cathepsin F, and cathepsin K. Western
blot analysis of SW756 cell lines showed no detectable cathepsin S
and K protein, while CTSL was present (Fig. 7i, positive control
for antibodies shown in Supplemental Fig. 6). Therefore, we
hypothesized that CTSL was the most-likely target of SERPINB3
in cervix tumor cells and generated stable knockout cell lines
using CRISPR-Cas9 targeting of CTSL in the SW756-B3-WT and
–B3-KO backgrounds (Fig. 7i). SW756-B3-KO/CTSL-KO cells
were protected from radiation-induced cell death compared to
SW756-B3-KO/CTSL-WT cells, while the absence of CTSL in the
SW756-B3-WT background did not impact response to radiation
(Fig. 7j).
Discussion
Since its isolation from human cervical tumors, SCCA has been
shown to serve as a strong and consistent indicator of poor
outcomes in cervical cancer and other types of cancers. While
10

others have shown that SCCA1/SERPINB3 promotes tumor
growth and resistance to cytotoxic agents, these data show that
SERPINB3 is directly responsible for radiation resistance of
cervical cancer cells by inhibiting a lysosome-mediated necrotic
cell death pathway. Moreover, we show that the effect of SERPINB3 loss on radiation sensitivity in cervical tumor cells is
similar if not greater than cisplatin, currently used as the standard of care to radiosensitize cervical cancer. These ﬁndings
suggest that SERPINB3 may serve as a therapeutic target for
radiosensitization of resistant cervical cancers. Additionally, the
data also implicate a lysosome-dependent regulated cell death
pathway termed lysoptosis in radiation-induced cell death and
resistance.
In contrast to other lysosome-dependent cell death mechanisms triggered by harsh mechanical disruption of the lysosomal
membrane27, lysoptosis is blocked by protease-inhibitory activity
of SERPINB3 in response to physiologic and pathologic stimuli
including hypotonic stress, and as we show here, by IR. Importantly, in the companion paper by Luke et al, we show that loss of
the cytoprotectant SERPINB3 sensitized cells to lysoptosis-like
death in response to diverse cytotoxic agents, including staurosporine, which classically induces apoptosis, H2O2, which
induces MTP-dependent necrosis in SERPINB3-WT cells, and
combination treatment (TNFα, SMAC mimetic, pan-caspase
inhibitor, and cyclohexamide) expected to induce necroptosis.
This suggests that upstream triggers of lysoptosis-like death may
converge on unabated lysosomal membrane permeability and
activity of lysosomal enzymes including cathepsin L when SERPINB3 is deleted.
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Ionizing radiation has a host of direct and indirect cellular
effects on tumor cells ultimately leading to recovery and survival,
or cell death. Direct damage to DNA and other macromolecules is
known to lead to the induction of apoptosis primarily in hematologic cells, but apoptosis is not a predominant mode of cell
death in most solid tumors. Following IR, the inability of the cell

to undergo mitosis secondary to dysfunctional cell cycle checkpoints and accumulated unrepaired DNA damage, entering a
state known as mitotic catastrophe, thought to ultimately lead to
cellular demise by secondary death pathways, or to enter a
senescent state28. However, the dynamics of radiation-induced
cell death, and the exact molecular mechanisms contributing to
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Fig. 7 SERPINB3 is sufﬁcient to protect cervical cancer cells against radiation-induced death, but requires a functional reactive site loop. a Western
blot of SiHa and C33A parental cervical tumor cell lines (P) which do not express SERPINB3 protein at baseline, and stable clones engineered to express
wild-type SERPINB3 (B3), SERPINB3-A341R mutant (A341R), or empty vector control (VC). b Clonogenic survival of SiHa cells expressing VC, B3 or B3A341R constructs, following increasing doses of RT, individual data points with ﬁt linear quadratic curve is shown. Dose modifying factor (DMF) displayed
with reference to VC. c Relative proliferation of C33A cells expressing VC, B3 or B3-A341R treated with RT normalized to Sham-treated cells at 24 h posttreatment, and measured by relative light units (RLU) of CellTiter-Glo luminescent reagent measuring cellular ATP. Individual data points (n = 6) are
shown mean indicated by bar height and standard deviations are plotted. P-value for one-way ANOVA shown. d, e Mean tumor volume curves of ﬂank
xenograft generated from C33A cells expressing VC, B3-wt or B3-A341R treated with sham (d) or 10 Gy tumor-directed radiation (e) with tumors
harvested at indicated time post-treatment. f Time to tumor doubling in days for each of the tumors. Individual data points are shown, tumors not doubling
by the termination of the experiment were included as a data point on the last day of the experiment. P-value for paired t-test between sham and 10 Gy
groups for each tumor type are shown. g Harvested tumors from sham (left) or 10 Gy (right) irradiated tumors from experiment shown above. h Fragments
per kilobase of transcript per million mapped reads (FPKM) of cysteine cathepsin protease gene transcripts in 68 patient specimens. CTSB and CTSH have
predominantly exopeptidase activity (exo>endo), CTSC and CTSX have exclusively exopeptidase activity (exo), and the remainder have exclusively
endopeptidase activity (endo). Inset shows the same data zoomed to 0–500 FPKM. i Western blot of SW756 cells with wild-type or knock SERPINB3 (B3WT and B3-KO, respectively) and wild-type or knockout cathepsin L (CTSL-WT and CSTL-KO respectively) Arrows indicate pro-, single chain, and mature
forms of cathepsin enzymes. j Representative histogram of percent Sytox + cells 96 h post-treatment with sham or 30 Gy in SW756-B3-WT/KO–CSTLWT/KO backgrounds. Multiple comparisons from one-way ANOVA is shown for indicated comparisons (ns non-signiﬁcant, ** = p-value < 0.01, **** = pvalue < 0.0001). Individual data points with bar height at the mean % Sytox-positive quantiﬁed in 2–4 ﬁelds of view of triplicate well (n = 3 per condition),
and is a representative one of three biologic replicate experiments.

the cell fate decision are complex. The most recent recommendations from the Nomenclature Committee on Cell death
describes myriad cell death subroutines, including cell-intrinsic
and –extrinsic modes27. Importantly, the committee stresses that
there is often a great deal of interconnectivity between signal
transduction cascades leading to one cell death mode versus
another. Therefore, in order to truly understand the relative
contributions of various lethal regulated cell death programs to
radiation-induced tumor cell kill, it is critical to evaluate not only
the presence of individual markers of cell death pathways at single
time points and under single conditions, but multiple markers of
suspected death modes at varying time points and dose levels. As
such, in this study we undertook a broad evaluation to determine
the intrinsic cell death routines contributing to radiation-induced
death in B3-KO cells compared to B3-WT cells. The goal was to
identify vulnerabilities exposed by the loss of SERPINB3 that can
be exploited for therapeutic radiosensitization.
The ﬁrst ﬁnding was the prevalence of necrotic morphology in
B3-KO cells following ionizing radiation. Although some endeffector caspase cleavage was detected by Western blot analysis,
this was only in HT3-B3-C and –B3-KO cells, and not in the
SW756 background. Moreover, morphology as determined by the
gold standard TEM showed a preponderance of necrosis and very
little evidence of apoptotic morphology. Thus, while caspasedependent cell death is induced by IR in HT3 cells, SERPINB3knockout exposes a vulnerability to predominantly necrotic
death. Pyroptosis is a form of necrotic regulated cell death typically induced by microbial pathogens, whereby cleavage of gasdermin D by caspase-1, or in some cases gasdermin E cleavage by
caspase-3, mediates its localization to the cell membrane. Gasdermin D-N or gasdermin E-N oligomerization forms pores
resulting in rapid permeabilization of the cell membrane29.
Despite some caspase-3 cleavage, we found no evidence of gasdermin D or E cleavage following radiation in either B3-WT or
B3-KO cells. Ferroptosis is another necrotic regulated cell death
mechanism which occurs independently of caspase activation and
relies heavily on generation of reactive oxygen species, a hallmark
of ionizing radiation30. Nevertheless, ferrostatin-1 did not inhibit
radiation-induced cell death in either B3-WT or B3-KO cells, and
TEM images of necrotic cells revealed largely intact mitochondria
suggesting ferroptosis is not a predominant form of radiationinduced cell death in B3-KO cells.
In C. elegans, the homolog of SERPINB3, srp-6, serves as an
intracellular cysteine protease inhibitor and was previously shown
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to protect animals against diverse toxic stressors by inhibiting
lysosomal proteases and subsequent animal death15. In addition
to hypo-osmotic conditions and heat shock, we also demonstrated that srp-6 null animals were more sensitive to oxidative
stress and hypoxia. Additionally, several groups have shown that
DNA damage induced by topoisomerase inhibitors camptothecin
and etoposide causes lysosomal membrane permeability31,32.
Therefore, we hypothesized that radiation, which causes both
DNA damage and accumulation of oxidative species, might
induce lysosomal membrane permeability in cervical cancer cells,
particularly in cells lacking SERPINB3. Indeed, we observed TEM
evidence of lysosome-like vesicle membrane rupture in B3-KO
tumor cells treated with ionizing radiation, and loss of lysosomotropic staining by live-cell microscopy in dying cells, similar to
that seen in srp-6 null C. elegans. Further supporting the idea that
SERPINB3 lysosomal protease inhibitor activity is responsible for
its ability to protect cells against radiation, we found that the
pharmacologic cysteine protease inhibitor E64d abrogated cell
death in B3-KO cells. Additionally, expression of wild-type but
not the RSL-mutant B3-A341R protected SERPINB3-low cervical
cancer cells from radiation further supporting the importance of
an intact RSL to bait-and-trap target lysosomal proteases released
from the lysosome after exposure to ionizing radiation. Guided by
expression patterns in primary cervix tumor samples, we identiﬁed cathepsin L as at least one of the cysteine protease targets of
SERPINB3 in cervical tumor cells that mediates radiationinduced cell death in the absence of SERPINB3.
While the DNA-damage repair capacity appears intact in B3KO cells, suggesting that inability to repair DNA damage is not
contributing to the radiosensitivity observed in these cells, we did
observe that the initial quantity of ɣH2AX foci, which is a surrogate for number of double strand DNA breaks, was higher in
B3-KO cells speciﬁcally in the HT3 background. The mechanism
of this is not clear and is under current scrutiny; however,
the myeloid and erythroid nuclear termination protein, a
chicken Clade B or intracellular SERPIN, is associated with
heterchromatin33, thus there is precedence for nuclear function of
SERPIN intracellular family proteins. Moreover, cysteine cathepsin proteases have been reported to localize to the nucleus34,35.
It is conceivable that nuclear cathepsins may have a role in vulnerability to DNA damage that is modiﬁable by the presence or
absence of SERPINB3. Perhaps more likely is a slightly different
kinetics of foci formation in the B3-WT and B3-KO cells that will
be discerned in future detailed analysis. Similarly, we observed
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some differences in baseline cell cycle distribution between B3KO and B3-WT cells. While these differences do not appear to
explain increased radiation sensitivity of B3-KO cells, since they
would predict B3-KO cells would be more radioresistant, this
observation is a focus of ongoing studies.
Importantly, we found similar effects of SERPINB3 on
radiation-induced cell death and resistance in cervical tumor cell
lines that are HPV positive and negative, and p53 wild-type and
mutant. These ﬁndings suggest that radiation-induced lysosomemediated necrosis proceeds in a manner that is not dependent on
functional p53.
The major limitation of the current study is the experimental
difﬁculty posed by the long time course of radiation-induced
death. Instead of minutes to hours required for classic cell death
inducers to result in cellular demise, most non-hematologic cells
treated with IR do not die for at least 48 h after treatment, and in
many cases several days after a single treatment. While we made
every effort to capture an accurate view of cell death modes
during each phase of this long time course, and in response to
various doses of radiation, it is possible that less prevalent cell
death events were not captured by Western blot, live-cell imaging
and TEM assays. Additionally, the time required to observe a
single cell death event using live-cell imaging inherently introduced difﬁculty in tracking cells while maintaining confocal
resolution. Finally, the complexity of signal transduction occurring in the hours to days after treatment with ionizing radiation
and the long time course of the experiments likely complicates the
interpretation of pharmacologic inhibitors of cell death.
While we are currently investigating the possibility, it remains
unclear if other cancer subtypes expressing SERPINB3 are protected against radiation in a similar manner. Given the available
evidence that SERPINB3 expression in many other cancers
including epithelial cancers of the head and neck, anus, lung,
esophagus as well as hepatocellular carcinoma carries a similar
poor prognosis, we expect this to be the case.
Taken together, this body of evidence contributes to the
understanding of regulated cell death occurring in tumor cells in
response to therapeutic ionizing radiation, and identiﬁed a targetable vulnerability, SERPINB3.
Methods
Guidelines and regulatory approvals. The methods were performed in accordance with relevant guidelines and regulations and approved by the Washington
University Institutional Biological & Chemical Safety Committee under protocol
#12737 (Ver.2.1). All mouse experiments were performed in accordance with
relevant guidelines and regulations and approved by the Washington University
Institute Institutional Animal Care and Use Committee (Protocol #20-0470).
Human subjects research was approved with informed consent by the Washington
University Institutional Review Board (No. 201105374).
Cell lines and tissue culture. All cell lines were obtained from ATCC and grown
in monolayer at 37 °C/5% CO2 in Dulbecco’s modiﬁed Eagle’s medium (DMEM)
or Iscove’s Modiﬁed Dulbecco’s Medium (IMDM) supplemented with 10% fetal
bovine serum, 0.1 mg/mL penicillin, 100 units/mL streptomycin, and 15 mM
Hepes. Generation and characterization of B3-KO and isogenic CRISPR-control
cell lines (B3-WT) SW756 and HT3 was described previously9. In brief, a singlevector lentiviral system was used, driving expression of Cas9 and the gRNA
sequence. KO was conﬁrmed by sequencing of the SERPINB3 gene, Western blot
showing no protein product, and sequencing of most-likely off-target genes to
conﬁrm speciﬁcity. SW756-B3-WT/cathepsin L knockout (B3-WT/CTSL-KO) and
SW756-B3-KO/cathepsin L knockout (B3-KO/CTSL-KO) lines were derived from
SW576 parental and –B3-KO clonal line, respectively, using a CTSL-targeting
guide RNA (GTGAGGAATCCTATCCATATG) in exon 5. Knockout was conﬁrmed in the pool cell line by Western blot and next generation sequencing,
verifying CTSL indels at a high percentage, resulting in a partial knockout cell line.
For the current paper, SiHa and C33A cell lines were engineered to stably express
pULTRA (Addgene 24129) mammalian vector driving expression of the wild-type
SERPINB3 gene, or SERPINB3 mutant encoding a single alanine to arginine substitution at amino acid 341 (B3-A341R).
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Irradiation of cell lines and mice. Cells in dishes were irradiated at a dose rate of
~300 cGy per minute using the RS-2000 Biological System (Rad Source, Suwanee,
GA), calibrated once monthly by a medical physicist. Sham irradiation conditions
were transported to the irradiator and placed at room temperature conditions while
delivering radiation. Mouse xenograft tumors were irradiated using the Xstrahl
Small Animal Radiation Research Platform (SARRP) 200 (Xstrahl Life Sciences,
Suwannee, GA). After being ﬁtted with a nose cone, mice were individually subjected to isoﬂurane anesthesia and imaged by on-board micro-computed tomography (CT). CT images imported into Muriplan were used to select an isocenter.
The tumor was then irradiated using anterior-posterior opposed beams using the
10 × 10 mm collimator at a dose rate of 3.9 Gy/min. Sham irradiated mice were
transported to the SARPP facility and remained in the room at the same conditions
during radiation of the irradiated mice.
Cell cycle analysis. Cells were seeded at 0.15 × 106 cells per well and treated 24 h
later with 4 Gy or Sham RT. Cells were ﬁxed and permeabilized with Triton-X-100
48 h later (after optimization of IR dose and incubation time), stained with propidium iodide, and cell cycle distribution determined using ﬂow cytometry of DNA
content. FlowJo™ Software (Becton, Dickinson and Company, Ashland, OR, USA)
was used to analyze and visualize the data.
Gamma-H2AX foci formation assay. Cells were seeded in 4-well chamber slides
(Nunc® Lab-Tek® II Chamber Slide™, C6807, Millipore Sigma, St Louis, MO, USA)
to 50-60% conﬂuence and allowed to adhere to the slide for 24 h. Cells were then
treated with sham or 2 Gy radiation as described in the Irradiation of cell lines and
mice section and incubated at 37 °C for 30 min or 24 h prior to washing with PBS
and ﬁxation with 3% PFA. Cells were then permeabilized with 0.1% Triton-X and
washed with PBS before blocking with blocking buffer (10% FBS, 0.5% BSA in PBS)
for 1 h at room temperature. Slides were incubated at 4 °C overnight with 1:300
anti-gH2AX antibody (05-636, Millipore Sigma, St Louis, MO, USA). Slides were
washed in three changes of PBS and incubated with 1:500 anti-mouse-IgG AlexaFluor 488 conjugated secondary antibody for 3 h at room temperature. Slides were
mounted with VECTASHIELD® HardSet™ Antifade Mounting Medium with DAPI
(H-1500, Vector Laboratories, Burlingame, CA, USA). Fluorescent images were
obtained on the Zeiss LSM510. Images were then analyzed using ImageJ Software
to quantitate foci per nucleus for a random selection of six 100X ﬁelds of view,
corresponding to 30–50 cells per condition.
Cell death assay. Cells were seeded in order to achieve 50–70% conﬂuence 24 h
later in a 96-well glass-bottom, opaque-walled dish (Greiner Bio-One™ CellStar™
µClear™ 96-Well, Cell Culture-Treated, Flat-Bottom Microplate, Fisher, 7000166).
24 h after plating, plates were treated with varying doses of IR or Sham, with 1 h
pre-incubation of inhibitors where indicated. Cisplatin was added 1 h prior to
radiation, where indicated, at the half-maximal inhibitory concentration (IC50) of
cisplatin monotherapy determined by Alamar blue assay (0.5μM for SW756 and
0.01μM for HT3). At established time points, Sytox™ orange (1:30,000, Fisher
Scientiﬁc, S11368) and Hoescht 33342 (1:2000) were added 15–30 min prior to
quantitative imaging on the Cytation™ 5 multi-mode reader (BioTek® Instruments,
Inc., Winooski, Vermont). Percent dead cells was determined by optimized automated counting of Sytox-positive cells divided by Hoescht-positive nuclei, averaged
over triplicate wells.
Western blot. Cells were seeded and treated as in the cell death assay methods,
except scaled to six-well or 10 cm dishes in order to obtain adequate cell lysate. At
established time points, coinciding with the cell death assay, cells were lysed with
Cell Lysis Buffer (Cell Signaling Technology, Danvers, MA) supplemented with
proteinase/phosphatase inhibitors and PMSF. Equal parts protein (25–30 μg) and
Laemmli sample buffer (Santa Cruz Biotechnology, Dallas TX) were boiled at 95 °C
for 10 min and gel electrophoresed on 4–20% gradient gels (Mini-Protean TGX,
Bio-Rad, Hercules, CA), transferred to PVDF blot using the Trans-Blot Turbo
Transfer system (Bio-Rad, Hercules, CA), blocked with 5% milk:TBS-Tween and
incubated with 1:4000 anti-SCCA1 antibody (NBP2, Novus International, Saint
Louis, MO) overnight at 4 °C, 1:100,000 anti-Actin (A5441, Santa Cruz Biotechnology, Dallas, TX), 1:2000 anti-GAPDH-HRP-conjugated antibody (D16H11,
Cell Signaling Technology, Danvers, MA) for 2 h at room temperature, 1:1000 antiGSMDC1 (NBP2-33422, Novus Biologicals, LLC, Littleton, CO) overnight at 4 °C,
1:1000 anti-p-MLKL (91689 S, Cell Signaling Technology, Danvers, MA) overnight
at 4 °C, 1:1000 anti-Cleaved Caspase-3 (9661, Cell Signaling Technology, Danvers,
MA) overnight at 4 °C,, 1:1000 anti-Cleaved Caspase-7 (8438, Cell Signaling
Technology, Danvers, MA) overnight at 4 °C, 1:1000 anti-Cleaved PARP (5625 s,
Cell Signaling Technology, Danvers, MA) overnight at 4 °C, 1:1000 anti-Full
Length PARP (9524 s, Cell Signaling Technology, Danvers, MA) overnight at 4 °C,
1:1000 anti-Caspase-7 (12827, Cell Signaling Technology, Danvers, MA) overnight
at 4 °C, 1:500 anti-Caspase-3 (sc-7272, Santa Cruz biotechnology, INC, Texas)
overnight at 4 °C, 1:1000 anti-RIP3 (57220, Cell Signaling Technology, Danvers,
MA) overnight at 4 °C, 1:1000 anti-RIPK3 (ser227) (93654 s, Cell Signaling
Technology, Danvers, MA) overnight at 4 °C, 1:1000 anti-RIPK1 (ser166) (44590,
Cell Signaling Technology, Danvers, MA) overnight at 4 °C, 1:10000 anti-p-ATM
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(ab81292-100UL, Abcam, Cambridge, MA) overnight at 4 °C, 1:1000 anti-ATM
(NB100-309, Novus Biologicals, LLC, Littleton, CO) overnight at 4 °C, 1:500 anticathepsin L-HRP (sc-32320, Santa Cruz Biotechnology, INC, Texas), 1:2000 anticathepsin S (AF1183, R&D Systems, Minneapolis, MN), and 1:1000 anti-cathepsin
K (sc-48353, Santa Crus Biotechnology, INC, Texas). Anti-mouse or anti-rabbit
HRP-conjugated secondary antibody was used for detection with ECL chemiluminescent reagent (GE Healthcare Life Sciences, Pittsburgh, PA), visualized, and
quantiﬁed using the Bio-Rad ChemiDoc MP imaging system and Image Lab
software (Bio-Rad, Hercules, CA).
Clonogenic cell survival assay. 500–1000 cells per well were seeded in 6-well
plates 24 h prior to treatment with increasing doses of radiation (2, 4, 6 Gy x 1) and
incubated for 1–3 weeks until control plates formed visible colonies (≥50 cells).
IC50 concentration of cisplatin was added 1 h prior to radiation, where indicated.
Plates were ﬁxed and stained with 0.5% Crystal Violet, 30% Methanol, 10% Acetic
Acid, 60% ddH2O for 30 min, rinsed in tap water and air dried at room temperature. Surviving fraction was calculated as the number of colonies ÷ (500 *
plating efﬁciency) and plotted on a log10 scale as per convention. The linear
quadratic equation was ﬁt to each dataset using GraphPad Prism 8©. The dose
modifying factor (DMF) was determined as the ratio of the dose resulting in 10%
surviving fraction compared to control, indicated as the reference condition.
Cell Titer-Glo survival assay. Cells were seeded to 50–70% conﬂuence in 96-well
dishes and cultured overnight prior to treatment with increasing doses of ionizing
radiation. 24 h later cells were washed once with PBS on ice then lysed directly in
the well using Cell Titer-Glo reagent and incubated per manufacturer’s protocol
prior to measurement of luminescence on the SpectraMax i3 plate reader (Molecular Devices, San Jose, CA). Mean relative light units (RLUs) normalized to
background value of a well with no cells was plotted with standard deviation.
Time-lapse confocal microscopy. Cells were seeded as described in the cell death
assay except on Nunc™ Lab-Tek™ II 8-well Chambered Coverglass (155409PK,
Thermo Scientiﬁc™) or 35 mm coverglass culture dishes (MatTek Life Sciences,
P35G-1.5-14-C), irradiated ~24 h after seeding and placed on the Leica TCS SP8 X
confocal microscope (Leica Microsystems Inc., Buffalo Grove, IL) beginning 24, 48,
72, or 96 h after IR and imaged every 20–30 min using a ×63/1.4 N.A. oil objective
for ~16 h at a time at 37 °C in 5% CO2 using an OKO-labs cage incubator. Prior to
imaging, cells were stained with LysoTracker™ Deep Red (Invitrogen™, Life Technologies Corp., Carlsbad, CA) for 15–30 min, washed twice with PBS and stained
with propidium iodide (1:500) in FluoroBrite DMEM media (Invitrogen, Life
Technologies Corp., Carlsbad, CA) with 10% FBS and 4mM L-glutamine. Images
were collected using LASX software (Leica Microsystems, Buffalo Grove, IL) and
visualized and analyzed using Volocity software (v6.3.5, Quorum). Image contrast
and brightness were adjusted for presented images in Microsoft PowerPoint with
similar adjustments for all images in the experiment (acquired with identical
microscope settings). As acquired images available for review.
Transmission electron microscopy. Cells were plated in 60 mm dishes to reach a
conﬂuence of ~70% at the time of RT, then treated 24 h after plating with sham,
10 Gy (HT3) or 30 Gy (SW756) RT. Cells were harvested by trypsinization 96 h
after treatment. For ultrastructural analyses, samples were ﬁxed in 2% paraformaldehyde/2.5% glutaraldehyde (Polysciences Inc., Warrington, PA) in 100 mM
sodium cacodylate buffer, pH 7.2 for 1 h at room temperature. Samples were
washed in sodium cacodylate buffer at room temperature and postﬁxed in 1%
osmium tetroxide (Polysciences Inc.) for 1 h. Samples were then rinsed extensively
in dH20 prior to en bloc staining with 1% aqueous uranyl acetate (Ted Pella Inc.,
Redding, CA) for 1 h. Following several rinses in dH20, samples were dehydrated in
a graded series of ethanol and embedded in Eponate 12 resin (Ted Pella Inc.).
Sections of 95 nm were cut with a Leica Ultracut UCT ultramicrotome (Leica
Microsystems Inc., Bannockburn, IL, USA), stained with uranyl acetate and lead
citrate, and viewed on a JEOL 1200 EX transmission electron microscope (JEOL
USA Inc., Peabody, MA, USA) equipped with an AMT 8 megapixel digital camera
and AMT Image Capture Engine V602 software (Advanced Microscopy Techniques, Woburn, MA).
Lactate dehydrogenase (LDH) enzyme activity assay. Cells were seeded to
50–75% conﬂuence in 96-well dishes and cultured overnight prior to treatment
with ionizing radiation. Spontaneous release of lactate dehydrogenase (LDH) was
conducted at 24 h time points following the kit protocol of the Cytotoxicity
Detection Kit (Roche, Indianapolis, Indiana, USA). Absorbance at 490 nm and
680 nm wavelengths was measured on the SpectraMax i3 plate reader (Molecular
Devices, San Jose, CA).
In vivo tumor growth and radiation response. Female athymic nude mice were
inoculated at 7–10 weeks of age with 0.5 × 106 cells suspended in a 1:1 mixture of
IMDM media and Matrigel® Matrix (Corning, Glendale, AZ, USA) subcutaneously
in the ﬂank region. Tumor growth was measured by caliper twice weekly beginning
at 3 days post-inoculation to determine estimated tumor volume assuming an
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ellipsoid sphere (V = 0.5*(L × W^2)), where V = volume, L = length of the longaxis, W = width of the short axis. Once tumors reached an appropriate size, animals were randomized to treatment with indicated doses of IR or sham IR on the
SARRP as described in Irradiation of cell lines and mice section. Following
monitored recovery from anesthesia, tumor growth was measured by caliper twice
weekly until tumors reached a maximal dimension of 20 mm or otherwise reached
a pre-deﬁned sacking criterion of skin ulcer.
Tumor tissue analysis by histology and immunohistochemistry. At tumor
harvest, mice were sacriﬁced using a CO2 asphyxiation chamber and tumors
immediately harvested and divided into three components for ﬂash freezing, into
4% paraformaldehyde (PFA), and ﬁxation buffer for TEM as described above.
PFA-ﬁxed tumor was sent and histology was performed by HistoWiz Inc.
(histowiz.com) using a Standard Operating Procedure and fully automated
workﬂow. Samples were processed, embedded in parafﬁn, and sectioned at 4μm.
Immunohistochemistry was performed on a Bond Rx autostainer (Leica Biosystems) using standard protocols. Antigen retrieval method was heat induced
epitope retrieval (HIER) at pH = 6.0 for 20 min (CC-3) and enzyme digestion for
10 min (TUNEL). Antibodies used were anti-cleaved-caspase-3 (Asp175) (Cell
Signaling, 9661 S, 1:300) and rabbit anti-rat secondary (Vector, 1:100). Bond
Polymer Reﬁne Detection Kit (Leica Biosystems, DS9800) was used according to
manufacturer’s protocol. After staining, sections were dehydrated and ﬁlm
coverslipped using a TissueTek-Prisma and Coverslipper (Sakura). Whole slide
scanning (×40) was performed on an Aperio AT2 (Leica Biosystems). TUNEL
staining was performed to determine TUNEL positive nuclei as a measure of
fragmented nuclear DNA under standard conditions using the Promega DeadEnd Fluorometric Detection System (Promega, G3250). QuPath V0.1.2 open
source software was used for digital image viewing and automated analysis using
macros for nuclear staining (TUNEL) and cytoplasmic staining (CC-3) to
determine percent cells positive. Positive control slides processed in batch under
identical conditions were used to optimize macros. Full digital slide images are
available at https://app.histowiz.com/shared_orders/2ccb0ce8-e4e1-41d1-8f75a0e621ced36e/slides/.
Whole-transcriptome RNA-sequencing (RNA-seq) analysis of lysosomal
cysteine cathepsins. Patients enrolled on a prospective tumor banking study with
written informed consent (Washington University IRB No. 201105374) submitted
pre-treatment tumor biopsies which were cryopreserved for future analysis. Tumor
samples with sufﬁcient high-quality RNA for whole-transcriptome sequencing
(RNA-seq), as deﬁned by the criteria utilized for The Cancer Genome Atlas
(TCGA), were included in this study, n = 68 patients36. Patient and treatment
characteristics of this cohort have been previously published37,38, and the full
RNA-seq datasets are available on Gene Expression Omnibus (GEO): (https://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE151666). This analysis of RNAseq data were approved by the Washington University IRB under protocol number
201710187.
Statistics and reproducibility. For animal experiments, based on our published
and preliminary in vitro data, using a Bonferroni correction with 0.05 signiﬁcance,
80% power and a two-sided t-test, we estimated needing 4 mice per group to
determine an effect size of 3.5 for tumor growth kinetics. Given an anticipated
tumor-take rate of 80% for HT3 and SW756 cell lines, we injected 5 mice per group
for those experiments. Because all of the mice injected developed tumors, we
included all in the experiment and analysis. For C33A cell line, tumor-take rate was
closer to 100% so 4 mice per group were injected. Only three mice in the C33A
group developed tumors. Tumor volume was estimated based on the twodimensional caliper measurements and equation for the volume of an ellipsoid
sphere: V = 0.5 * (L × W2), and means were plotted with standard error for the
group. Two-way ANOVA with Bonferroni correction was performed to determine
difference between mean tumor growth curves. Students’ t-test was used to compare groups in ﬂow cytometry, cell death, TEM quantiﬁcation and histology (CC-3
and TUNEL) assays, unless where otherwise indicated. Individual clonogenic
survival data points were ﬁt with the linear quadratic equation, and dose modifying
factors (DMF) were calculated at 10% surviving fraction. In all cases, p-value of
<0.05 was considered signiﬁcant. All cell-line-based experiments were performed in
triplicate with at least three biologic replicates, except as noted in the ﬁgure legends.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.

Data availability
All raw data included in this manuscript including but not limited to source data
underlying all graphs and charts, raw blot images, live-cell image videos, and TEM
images are available at: https://data.mendeley.com//datasets/8465mbnxt7/1. Full IHC
slide images are available at: https://app.histowiz.com/shared_orders/2ccb0ce8-e4e141d1-8f75-a0e621ced36e/slides/. RNA-seq transcriptomic data are available on Gene
Expression Omnibus (GEO): accession number: GSE151666. Plasmid backbones are
available on addgene (#52961, #24129) and Takara Bio USA (631334). Plasmids and
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sequences with gene of interest inserts are available upon request by contacting the
corresponding author.
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